ALPS Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,950
Closed -$1.19M 1048
2022
Q3
$1.19M Sell
52,950
-4,370
-8% -$126K 0.01% 414
2022
Q2
$1.42M Buy
+57,320
New +$1.58M 0.01% 376
2021
Q2
Sell
-130,688
Closed -$10.8M 909
2021
Q1
$10.8M Buy
130,688
+6,320
+5% +$606K 0.11% 142
2020
Q4
$11.3M Buy
124,368
+13,621
+12% +$846K 0.13% 140
2020
Q3
$4.43M Buy
110,747
+4,768
+4% +$166K 0.07% 167
2020
Q2
$3.64M Sell
105,979
-31,454
-23% -$937K 0.05% 179
2020
Q1
$3.05M Sell
137,433
-14,724
-10% -$372K 0.05% 178
2019
Q4
$2.98M Buy
152,157
+21,771
+17% +$346K 0.02% 195
2019
Q3
$2.02M Sell
130,386
-6,048
-4% -$116K 0.02% 209
2019
Q2
$2.77M Sell
136,434
-19,404
-12% -$350K 0.02% 197
2019
Q1
$2.74M Buy
155,838
+6,735
+5% +$106K 0.02% 196
2018
Q4
$1.91M Buy
149,103
+54,571
+58% +$761K 0.01% 224
2018
Q3
$1.54M Buy
94,532
+17,818
+23% +$211K 0.01% 288
2018
Q2
$870K Buy
+76,714
New +$845K 0.01% 364

Other funds holding FATE